Cyclic AMP serves as an important second messenger transmitting extracellular signals (including those from a variety of hormones and neurotransmitters) to modulate such diverse phenomena as metabolism, gene transcription and memory. The regulation of adenylyl cyclases, the enzymes that convert ATP to cyclic AMP, is the key step in controlling the intracellular concentration of cyclic AMP. So far, cDNAs encoding six mammalian adenylyl cyclases have been cloned (and named types I-VI in the order of their discovery) [ 1-91, The cloned cDNAs make it possible to study the regulation of each type of enzyme individually. Hased on their amino acid sequence similarity, types V and VI adenylyl cyclases are more related to each other than they are to the other four enzymes, as are types I1 and IV. The tissue distributions of adenylyl cyclases have been examined by estimating the quantity of messenger RNA. Types I, I1 and I11 adenylyl cyclases display a more restricted pattern of expression than do the other three enzymes. Types I and I1 adenylyl cyclases are most abundant in brain, whereas the type I11 enzyme is found mostly in olfactory neuroepithelium. The expression of each protein remains to be analysed in detail.
Cyclic AMP serves as an important second messenger transmitting extracellular signals (including those from a variety of hormones and neurotransmitters) to modulate such diverse phenomena as metabolism, gene transcription and memory. The regulation of adenylyl cyclases, the enzymes that convert ATP to cyclic AMP, is the key step in controlling the intracellular concentration of cyclic AMP. So far, cDNAs encoding six mammalian adenylyl cyclases have been cloned (and named types I-VI in the order of their discovery) [ 1-91, The cloned cDNAs make it possible to study the regulation of each type of enzyme individually. Hased on their amino acid sequence similarity, types V and VI adenylyl cyclases are more related to each other than they are to the other four enzymes, as are types I1 and IV. The tissue distributions of adenylyl cyclases have been examined by estimating the quantity of messenger RNA. Types I, I1 and I11 adenylyl cyclases display a more restricted pattern of expression than do the other three enzymes. Types I and I1 adenylyl cyclases are most abundant in brain, whereas the type I11 enzyme is found mostly in olfactory neuroepithelium. The expression of each protein remains to be analysed in detail.
Two signalling pathways are known to regulate the activity of mammalian adenylyl cyclases. Receptors for many hormones and neurotransmitters activate heterotrimeric G-proteins (a-, B-and y-subunits) that either stimulate (G,) Each of the six types of adenylyl cyclases has been expressed in Sf9 cells using the baculovirus expression system [ 121. Isolated plasma membranes containing each enzyme subtype were reconstituted with the purified regulatory components to study the regulation of their enzyme activity. Each of six types of adenylyl cyclase can be activated by the GTPyS-bound a-subunit of G, (G,). Only types I and I11 adenylyl cyclases are sensitive to stimulation by Ca'+ -calmodulin. Interestingly, there is strong synergism between activated G,, and Ca'+ -cab modulin on the activity of type I adenylyl cyclase, indicating the potential for cross-talk between two signalling pathways (Figure 3b) . Such synergistic activation has been reported for plasma membranes from rat brain and from Ap(ysia neurons [ 13, 141. Unexpected type-specific regulation of adenylyl cyclase activity by G-protein b y-su bunits
The adenylyl cyclase activities in the S40 cell and in platelet membranes, which were used originally to characterize the effects of G-proteins, are activated by G,,, but are largely insensitive to exogenously added G-protein &subunits [lo] . Therefore, as each subtype of adenylyl cyclase was examined, we were surprised to observe a prominent type-specific regulation of these enzymes [ 151. As expected, G,, activated all six adenylyl cyclases; B y added alone had essentially no effect (Figure la) . However, By inhibited the type I enzyme when stimulated either by GTPyS-bound Gs, or by Ca'+-calmodulin (Figure l a ) [ 15, 161 . In contrast, By potentiated the are well-conserved among the different adenylyl cyclases (50-92% sequence identity), they are similar to each other and to the catalytic domain of guanylyl cyclases [23] .
Expression of either the N-terminal (NM,C,)
or the C-terminal (M2C2) half of type I adenylyl cyclase alone leads to products with little catalytic activity. However, co-expression of the two halves restores regulated enzymic activity [ 161. Interestingly,. co-expression of the type I N-terminal half (INM,C,) and the type I1 C-terminal half (IIM2C2) 
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Effects of G-protein &subunits on type 1/11 adenylyl cyclase chimeras Construction of chimeras: cDNA for chimera B was constructed by 'sticky-foot'-directed mutagenesis using two 45mers with the 30 base desired sequences from type I adenylyl cyclase and 15 bases from type I 1 adenylyl cyclase [39] . cDNA for chimera B' was constructed from chimera B by introducing a termination codon at amino acid residue 1071 of type I adenylyl cyclase using the method described by Kunkel [a] . For the construction of chimera 1/11, a restriction enzyme Hpol site was introduced into both types I and II adenylyl cyclases (at a sequence corresponding t o amino acid residues 606-607 and 616-617 respectively) by the method described by Kunkel (c) Effects of B y on rGs,-activated type I and type I 1 and chimeric adenylyl cyclases. Sf9 cell membranes were first incubated with GTPyS-rG,, for 10 min at 30°C and then assayed for adenylyl cyclase activity in the presence of the indicated concentrations of purified recombinant B, ys.
The final concentration of GTPyS-rG,, was 50 nM. Without PI ys, the specific activities of type I, type 11, chimera 1/ 11, chimera B and chimera B' (indicated as 100%) were 4.4, 9.9, 3.5, I .7 and I .9 nmol of cyclic AMP per min per mg of membrane protein respectively. Volume 21
Cross-talk between Receptors and lntracellular Second Messenger Systems insensitive to Ca2+ -calmodulin. The G,,-activated activity of this complex can be increased further by By, although the magnitude of enhancement is reduced. These results suggest that the C-terminal half of the adenylyl cyclase has the determinant for the &mediated response. Unfortunately, the reverse construct (IINM,C, x IM,C,) was inactive.
T o define the domain that is responsive to By further, a number of covalent chimeras between type I and type I1 adenylyl cyclases were constructed and tested for activity (Figure 2 ). Consistent with the results of the non-covalent chimera, chimera 1/11 responded to forskolin and G,,, but was insensitive to CaL + -calmodulin. It also retained the ability (although at a reduced level) to be activated by the G-protein By-subunit when stimulated by Interestingly, these properties are preserved in both chimeras €3 and R', in which only the C,, region of type I1 adenylyl cyclase was replaced These results suggest tentatively that CzZl region of the type I enzyme is required for Ca'+-calmodulin sensitivity. Unfortunately, the II/I chimera (the reverse of 1/11) was inactive, and so we could not test whether C,, of the type I enzyme could convert adenylyl cyclase from a calmodulin-insensitive to a calmodulin-sensitive form.
Physiological significance of Bymediated regulation of adenylyl cyclase activity
The concentration of By required to modulate adenylyl cyclase activity is significantly greater than that of GSa. Thus it appears that the G, oligomer could not be the source for the regulation of By 
3.
3. attenuation. The activity of type I adenylyl cyclase, which is stimulated by signals from G,-coupled receptors (Figure 3d i) or by elevation of intracellular CaL+ (Figure 3d ii), can be attenuated by B y release from Go. Signal attenuation can also be accomplished by the release of activated G,,, particularly with types V and VI adenylyl cyclases. This is presumed to be the major mechanism for the inhibition of adenylyl cyclase in non-neuronal tissues [24] . The third is the selected signal blockade. Signals that activate G,,-or G,-coupled receptors could activate phospholipase C p that could, in turn, lead to an increase in intracellular CazC concentration and then to the activation of calmodulin [26] . This mechanism may well underlie the synergistic effects of neurotransmitters on cyclic AMP accumulation in brain slices [27] . In addition, the same mechanism could also explain the potentiation of the effects of B-adrenergic agonists by y-aminobutyric acid or 5-hydroxytryptamine on the Ca'+-activated afterhyperpolarization of pyramidal neurons in the hippocampus [ZS] .
Since the discovery of the heterotrimeric structure of G-proteins, significant effort has been focused on delineating the roles of the dissociated a-and By-subunits that are generated on stimulation by hormones and by neurotransmitters [ 10, 18, 
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291. G-protein a-subunits have been shown to activate directly adenylyl cyclases, cyclic GMP phosphodiesterase and phospholipase Cg (by the a-subunits of GJG,, G, and G, families respectively) [ 10, 25, 301 . The functions of the G-protein By subunits in the direct regulation of downstream effectors have just begun to be appreciated widely.
Either By or a subunits have been shown to activate the acetylcholine-regulated K channel of atrial myocytes [31, 321 . Genetic analysis of the pheromone signalling pathway in Saccharomyces cereviszize indicates clearly that the G-protein By, but not a , regulates the downstream event [33] . After the observation of type-specific regulation of adenylyl cyclases by By, two more &regulated effectors have been identified. G-protein p ysubunits alone can activate various forms of phospholipase C/? [34] . It is probable that this effect of By could underlie the mechanism of pertussistoxin-sensitive phosphoinositol-mediated responses, differing from the pertussis-toxin-insensitive release of diacylglycerol and inositol 1,4,5-trisphosphate that is mediated by the G-protein a-subunits of the G, family (G,,, GI,,, G14a and [25] . Another function that has been proposed for the G-protein Together with arrestin molecules, phosphorylation of receptors results in the desensitization of the receptors. Concurrently, it was found that overexpression of ste20, a protein kinase C homologue, could suppress the dominant-negative alleles of ste4 (G-protein p homologue), indicating that this kinase could be the downstream effector of G-protein By in budding yeast [37] . The demonstration that both G-protein a-and By-subunits serve as determinants for signal transduction permits great diversity and cross-talk between different signal transduction pathways.
Introduction
Airway smooth muscle controls airway calibre and therefore determines alveolar ventilation. Disease states such as asthma are characterized by an increased muscle tone and airways resistance, which are due, at least in part, to changes in the response of airway smooth muscle to endogenously generated stimuli [ 11. Clearly, an understanding of the physiological and pathophysiological regulation of smooth muscle tone is central to the development of novel therapeutic approaches for the treatment of airway hyper-reactivity.
In this brief review, we attempt to summarize some of the progress that has been made recently in our understanding of phosphoinositide signalling in airway smooth muscle, with a particular emphasis on how changes in cyclic nucleotides and membrane potential may modulate the phosphoinositide cycle.
Contractile agonists and phosphoinositide turnover
Contraction of airway smooth muscle can be provoked by a variety of agents (termed spasmogens) that interact with cell-surface receptors to effect pharmacomechanical coupling [2, 31. Agents may be released endogenously from neurons, may be blood-borne or may be released from pro-inflammatory cells that can infiltrate the airways under Abbreviations used: DAG, diacylglycerol; PI-PLC, phosphoinositide-specific phospholipase C. certain circumstances [4] . Although many spasmogenic agents cause significant depolarization of airway smooth muscle, it is generally considered that it is their ability to stimulate phosphoinositide- bradykinin (via B2) [7] , endothelin [8] and a variety of other agents including neuropeptides (for example, tachykinins [9] ) and mediators (for example, leukotrienes [ lo] and thromboxanes [ 111) can all evoke an increase in phosphoinositide turnover in preparations of airway smooth muscle. Although the majority of these receptors appear to recruit G-proteins of the pertussis-toxin-insensitive G, family selectively to stimulate PI-PLC [3, 12, 131, there is evidence that some agents (for example, leukotriene D, [ 101) act via pertussis-toxin-sensitive transduction mechanisms.
In some cases, most notably for M,-muscarinic and HI-histaminergic receptor activation, the time-course, concentration-dependency and pattern of inositol (po1y)phosphate generation has been investigated in some detail. Muscarinic receptor agonists or histamine cause a sustained activation of 31.
